Dayvigo 5mg Tablet

Dayvigo 5mg tablet contains lemborexant as the active component. This medication is an orexin receptor antagonist, a class with a lower risk of physical dependence and withdrawal symptoms compared to traditional sleep medications such as benzodiazepines and certain other sedative-hypnotics.

Dayvigo 5mg tablet is used for the treatment of insomnia, a common sleep disorder characterised by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep. This medication can help individuals with insomnia fall asleep faster and stay asleep longer. It may reduce the time it takes to fall asleep and decrease the number of awakenings during the night, leading to a more restful sleep experience. By promoting better sleep quality and duration, this medication can help reduce daytime sleepiness and fatigue, which can improve daytime functioning, cognitive performance, and overall well-being.

If an individual has a known allergy or hypersensitivity to lemborexant or its components, use of this medication should be avoided. Inform your healthcare provider about any pre-existing medical conditions, such as gastrointestinal disorders, liver disease, kidney disease, or other health conditions. These may require special precautions or adjustments in the use of this medication.

Older adults may be more sensitive to the effects of Dayvigo 5mg tablet, including drowsiness and impaired coordination. Individuals with severe respiratory impairment, including conditions such as obstructive sleep apnea, may be at a higher risk of respiratory depression when taking this medication. The medication should be used cautiously and under close medical supervision in these cases. This medication should be used cautiously in individuals with a history of sleep-related breathing disorders due to the potential for worsening these conditions.

Dayvigo 5mg tablet is used to treat the following: Sleep disorder

Dayvigo 5mg tablet exerts its therapeutic effect as a sleep aid by selectively blocking orexin receptors in the brain. Doing so modulates the signaling pathways responsible for promoting wakefulness and maintaining alertness. This action helps to decrease the time it takes to fall asleep and enhances the overall quality and duration of sleep. Its precise targeting of orexin receptors offers a unique advantage, potentially leading to improved sleep without significant daytime drowsiness or the risk of physical dependence commonly associated with other sleep medications.

Dayvigo 5mg tablet is typically administered orally, shortly before bedtime. The recommended dosage is determined by individual factors and the severity of insomnia. It should be taken without food, and alcohol or other sedatives should be avoided to prevent excessive drowsiness and impaired coordination.

Dayvigo 5mg tablet causes some side effects like all medications, although not everyone will experience them. Serious Sleep-related behaviors Allergic reactions Common Headache Somnolence (excessive sleepiness) Dizziness Fatigue Abnormal dreams Insomnia (paradoxical wakefulness) Upper respiratory tract infection

Dayvigo 5mg tablet potential to induce drowsiness and impair cognitive and motor skills demands caution when engaging in activities such as driving or operating machinery. Alcohol and other sedatives should be avoided, as their combination with this medication can intensify sedation. Individuals with liver impairment need careful monitoring and potential dose adjustments due to the medication's metabolism. Its safety during pregnancy and breastfeeding is uncertain, necessitating a thorough discussion with a healthcare provider before use. Elderly individuals might be more sensitive to the drug's effects and may require lower dosages. As with any medication, a comprehensive review of medical history and current medications is vital to ensure that this medication is used safely and effectively.